TickerGuard
Buy Day today: Poor (57) Mixed market breadth · today: Nonfarm Payrolls (September)
RNA

Atrium Therapeutics, Inc.

Healthcare · Biotechnology

8.10$ -1.8% vs. previous close Closing price · As of: Oct 1, 2026

Statements

Cash Flow

All figures per share in USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow RNA
Line item 2011 2012 2013 2018 2019 2020 2021 2022 2023 2024 2025
– – – -0.47 0.07 -1.71 -2.29 -2.61 -1.63 -2.70 -2.40
– – – 0.02 0.01 0.02 0.02 0.03 0.03 0.02 0.02
– – – 0.00 0.01 0.20 0.41 0.52 0.52 0.46 0.45
– – – 0.02 0.20 0.21 0.42 0.51 – – –
– – – 0.03 0.51 0.11 0.13 0.19 0.84 -0.13 -0.01
– – – 0.00 0.01 0.05 0.09 0.05 0.06 0.06 0.08
– – – 0.00 -0.01 -0.36 -1.99 -3.64 -1.78 -7.66 -0.08
– – – 0.01 0.00 0.02 0.00 – – – –
– – – 0.01 1.94 0.02 – – – – –
– – – 0.24 0.44 -0.22 0.00 0.00 – – –
– – – 0.25 2.38 12.56 4.26 6.64 1.29 10.69 2.49
– – – -0.22 2.44 10.48 -0.02 0.38 -2.13 0.33 9.50
– – – -0.47 0.06 -1.76 -2.38 -2.67 -1.69 -2.76 -2.49

Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?